Stock Earnings

Question 1

How did VRDN's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Viridian Therapeutics Inc is $-0.34, not beating expectations of $-1.1.

Question 2

How did Viridian Therapeutics Inc VRDN's revenue perform in the last quarter?

Accepted Answer

Viridian Therapeutics Inc revenue for the last quarter is $-0.34

Question 3

What is the revenue estimate for Viridian Therapeutics Inc?

Accepted Answer

According to 16 of Wall street analyst, the revenue estimate of Viridian Therapeutics Inc range from $57.75M to $0.0

Question 4

What's the earning quality score for Viridian Therapeutics Inc?

Accepted Answer

Viridian Therapeutics Inc has a earning quality score of B+/52.699963. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Viridian Therapeutics Inc report earnings?

Accepted Answer

Viridian Therapeutics Inc next earnings report is expected in 2026-02-03

Question 6

What are Viridian Therapeutics Inc's expected earnings?

Accepted Answer

Viridian Therapeutics Inc expected earnings is $34.58K, according to wall-street analysts.

Question 7

Did Viridian Therapeutics Inc beat earnings expectations?

Accepted Answer

Viridian Therapeutics Inc recent earnings of $70.56M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-1.1	$-0.34	-69.09%	MISSED
Q2 '25	$-1.02	$-1.0	-1.96%	MISSED
Q1 '25	$-0.98	$-0.87	-11.22%	MISSED
Q4 '24	$-1.05	$-1.0	-4.76%	MISSED
Q3 '24	$-1.07	$-1.14	+6.54%	BEAT

Viridian Therapeutics Inc (VRDN) Price

VRDN Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ